Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
5650studies shown
Showing 3,937-3,948 of 5,650
Drug study icon
RecruitingNCT06269146

Pramipexole to Enhance Social Connections

This study is comparing Pramipexole Pill with placebo for people with anxiety, Depression, or Social Disconnection. Participants receive Pramipexole Pill or placebo and complete study visits and assessments.

Multiple locations, including San Diego
Anxiety, DepressionDrugA study involving a medication or substance.From 18 Years to 50 Years
Countries
United States
Sponsor
University of California, San Diego
Condition
Anxiety, Depression
Other study type icon
RecruitingISRCTN72151939

Pramipexole study for Depression in bipolarity

This study is looking at whether a digital support tool can help people with Treatment-resistant Depression in bipolarity, Mental and Behavioural Disorders, or Bipolarity. Participants receive a study treatment and complete follow-up visits and assessments.

In United Kingdom
Bipolarity, DepressionOtherOver 18 Years
Countries
United Kingdom
Sponsor
Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust
Condition
Bipolarity, Depression
Behavioral study icon
RecruitingNCT04793685

Prazosin for Addiction With Withdrawal Symptoms

This summary needs review. Please check the official study record and contact the research team for details.

In New Haven
AddictionBehavioralFrom 18 Years to 70 Years
Countries
United States
Sponsor
Yale University
Condition
Addiction
Other study type icon
RecruitingISRCTN61562706

PRAZosin for people with OCD

This summary needs review. Please check the official study record and contact the research team for details.

In Netherlands
OCDOtherFrom 18 Years to 70 Years
Countries
Netherlands
Sponsor
Academic Medical Centre (AMC) (Netherlands)
Condition
OCD
Drug study icon
RecruitingNCT05527210

Prebiotic Treatment in People With Schizophrenia

This study is looking at care and outcomes for people with Schizophrenia or schizoaffective disorder. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.

In Catonsville
SchizophreniaOtherFrom 18 Years to 60 Years
Countries
United States
Sponsor
University of Maryland, Baltimore
Condition
Schizophrenia
Behavioral study icon
RecruitingNCT07011901

Precision Analytic Research Methods in OCD

This summary needs review. Please check the official study record and contact the research team for details.

In New York
OCDBehavioralFrom 18 Years to 55 Years
Countries
United States
Sponsor
Icahn School of Medicine at Mount Sinai
Condition
OCD
Device study icon
RecruitingNCT07196462

Precision Brain Stimulation to Reduce Cannabis Craving in Schizophrenia

This study is comparing 3 Minute iTBS to the L DLPFC with Precision Brain Stimulation for Cannabis Users with Healthy Controls for people with Cannabis Use, Schizophrenia, Psychosis, or Rtms. Participants receive 3 Minute iTBS to the L DLPFC or Precision Brain Stimulation for Cannabis Users with Healthy Controls and complete study visits and assessments.

In Nashville
SchizophreniaDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 65 Years
Countries
United States
Sponsor
Vanderbilt University Medical Center
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.